Intrua Financial, LLC Charles River Laboratories International, Inc. Transaction History

Intrua Financial, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$204.13 - $302.4 $6,532 - $9,676	-32 Reduced 3.15%	984 $211,000
Q1 2022 May 11, 2022	BUY	$255.51 - $362.11 $20,696 - $29,330	81 Added 8.66%	1,016 $289,000
Q4 2021 Feb 14, 2022	BUY	$351.38 - $448.68 $4,567 - $5,832	13 Added 1.41%	935 $352,000
Q3 2021 Oct 28, 2021	BUY	$372.64 - $458.3 $3,726 - $4,583	10 Added 1.1%	922 $397,000
Q2 2021 Aug 12, 2021	BUY	$294.17 - $371.65 $13,531 - $17,095	46 Added 5.31%	912 $364,000
Q1 2021 Apr 30, 2021	BUY	$249.67 - $299.48 $4,743 - $5,690	19 Added 2.24%	866 $290,000
Q4 2020 Feb 03, 2021	BUY	$222.0 - $252.62 $188,034 - $213,969	847 New	847 $212,000

709

50M

122K

239K

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $5.42B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

Get notified when there are updates to the investment portfolio of Intrua Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Intrua Financial, LLC with notifications on news.